English

BIOFORM MEDICAL INC

EDGAR

Quarterly report (10-Q) · filed 2010-02-16

10 filing records in this dataset, filed from 2007-12-19 to 2010-02-16. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

21.8 million USD

2009-12-31 · USD

Exact inputs and evidence

Revenue: 21785000 USD Source

Net margin

7.27%

2009-12-31 · %

Exact inputs and evidence

Net Income: 1584000 USD Source
Revenue: 21785000 USD Source

Operating cash flow

3.89 million USD

2009-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 4582000 USD Source
Operating Cash Flow: 692000 USD Source

Free cash flow

3.6 million USD

2009-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 4582000 USD Source
Operating Cash Flow: 692000 USD Source
Capital Expenditure: 419000 USD Source
Capital Expenditure: 128000 USD Source

Cash and cash equivalents: 46.1 million USD 2009-12-31 Source
Exact value

46102000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

74.2 million USD

2009-01-01 – 2009-12-31

Exact inputs and evidence

Revenue: 14991000 USD · 2009-01-01 – 2009-03-31 Source
Revenue: 66518000 USD · 2008-07-01 – 2009-06-30 Source
Revenue: 47348000 USD · 2008-07-01 – 2009-03-31 Source
Revenue: 18272000 USD · 2009-07-01 – 2009-09-30 Source
Revenue: 21785000 USD · 2009-10-01 – 2009-12-31 Source

Net income

-4.42 million USD

2009-01-01 – 2009-12-31

Exact inputs and evidence

Net income: -3565000 USD · 2009-01-01 – 2009-03-31 Source
Net income: -21119000 USD · 2008-07-01 – 2009-06-30 Source
Net income: -19242000 USD · 2008-07-01 – 2009-03-31 Source
Net income: -559000 USD · 2009-07-01 – 2009-09-30 Source
Net income: 1584000 USD · 2009-10-01 – 2009-12-31 Source

Operating cash flow

1.74 million USD

2009-01-01 – 2009-12-31

Exact inputs and evidence

Operating cash flow: -17879000 USD · 2008-07-01 – 2009-03-31 Source
Operating cash flow: -13816000 USD · 2008-07-01 – 2008-12-31 Source
Operating cash flow: -16657000 USD · 2008-07-01 – 2009-06-30 Source
Operating cash flow: -17879000 USD · 2008-07-01 – 2009-03-31 Source
Operating cash flow: 692000 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: 4582000 USD · 2009-07-01 – 2009-12-31 Source
Operating cash flow: 692000 USD · 2009-07-01 – 2009-09-30 Source

Capital expenditure

812 thousand USD

2009-01-01 – 2009-12-31

Exact inputs and evidence

Capital expenditure: 835000 USD · 2008-07-01 – 2009-03-31 Source
Capital expenditure: 614000 USD · 2008-07-01 – 2008-12-31 Source
Capital expenditure: 1007000 USD · 2008-07-01 – 2009-06-30 Source
Capital expenditure: 835000 USD · 2008-07-01 – 2009-03-31 Source
Capital expenditure: 128000 USD · 2009-07-01 – 2009-09-30 Source
Capital expenditure: 419000 USD · 2009-07-01 – 2009-12-31 Source
Capital expenditure: 128000 USD · 2009-07-01 – 2009-09-30 Source

Free cash flow

929 thousand USD

2009-01-01 – 2009-12-31

Exact inputs and evidence

Operating cash flow: -17879000 USD · 2008-07-01 – 2009-03-31 Source
Operating cash flow: -13816000 USD · 2008-07-01 – 2008-12-31 Source
Operating cash flow: -16657000 USD · 2008-07-01 – 2009-06-30 Source
Operating cash flow: -17879000 USD · 2008-07-01 – 2009-03-31 Source
Operating cash flow: 692000 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: 4582000 USD · 2009-07-01 – 2009-12-31 Source
Operating cash flow: 692000 USD · 2009-07-01 – 2009-09-30 Source
Capital expenditure: 835000 USD · 2008-07-01 – 2009-03-31 Source
Capital expenditure: 614000 USD · 2008-07-01 – 2008-12-31 Source
Capital expenditure: 1007000 USD · 2008-07-01 – 2009-06-30 Source
Capital expenditure: 835000 USD · 2008-07-01 – 2009-03-31 Source
Capital expenditure: 128000 USD · 2009-07-01 – 2009-09-30 Source
Capital expenditure: 419000 USD · 2009-07-01 – 2009-12-31 Source
Capital expenditure: 128000 USD · 2009-07-01 – 2009-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-02-16.

Financial data available through: 2009-06-30.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2009-06-30
Operating income: 4 of 11 periods available· newest 2009-06-30
Net income: 4 of 11 periods available· newest 2009-06-30
Operating cash flow: 4 of 11 periods available· newest 2009-06-30
Capital expenditure: 4 of 11 periods available· newest 2009-06-30
Total assets: 3 of 11 periods available· newest 2009-06-30
Total liabilities: 3 of 11 periods available· newest 2009-06-30
Current assets: 3 of 11 periods available· newest 2009-06-30
Current liabilities: 3 of 11 periods available· newest 2009-06-30
Cash and cash equivalents: 4 of 11 periods available· newest 2009-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-1.4%

Prior period

USD 67.48 million

2007-07-01 – 2008-06-30
Current period

USD 66.52 million

2008-07-01 – 2009-06-30

Exact inputs and evidence

66518000 − 67483000 = -965000 USD

67483000 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
66518000 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Year-over-year change in Revenue: -965000 USD Concept: fundies:Revenue Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 66518000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#5590 Input fundies:Revenue: 67483000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#5590
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 8.41 million

Prior period

−USD 29.53 million

2007-07-01 – 2008-06-30
Current period

−USD 21.12 million

2008-07-01 – 2009-06-30

Exact inputs and evidence

-21119000 − -29525000 = 8406000 USD

-29525000 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
-21119000 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Year-over-year change in Net income: 8406000 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21119000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7192 Input fundies:NetIncome: -29525000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7192
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 8.15 million

Prior period

−USD 24.81 million

2007-07-01 – 2008-06-30
Current period

−USD 16.66 million

2008-07-01 – 2009-06-30

Exact inputs and evidence

-16657000 − -24806000 = 8149000 USD

-24806000 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
-16657000 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Year-over-year change in Operating cash flow: 8149000 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -16657000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444 Input fundies:OperatingCashFlow: -24806000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-77%

Prior period

USD 4.39 million

2007-07-01 – 2008-06-30
Current period

USD 1.01 million

2008-07-01 – 2009-06-30

Exact inputs and evidence

1007000 − 4385000 = -3378000 USD

4385000 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
1007000 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Year-over-year change in Capital expenditure: -3378000 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1007000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486 Input fundies:CapitalExpenditure: 4385000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2008-07-01 – 2009-06-30

Revenue USD 66.52 million 100% of revenue
Cost of revenue USD 13.02 million 20% of revenue
Operating expenses USD 74.37 million 112% of revenue
Operating income −USD 20.87 million −31% of revenue
Tax, interest and other Derived USD 250,000 0.4% of revenue
Net income −USD 21.12 million −32% of revenue

Cash

Operating cash flow −USD 16.66 million −25% of revenue
Capital expenditure USD 1.01 million 1.5% of revenue
Free cash flow Derived −USD 17.66 million −27% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Operating loss: operating costs were 151% of revenue.
2007 Operating loss: operating costs were 130% of revenue.
2008 Operating loss: operating costs were 146% of revenue.
2009 Operating loss: operating costs were 131% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2005-07-01 – 2006-06-30	22650000	34258000 Derived	-11608000	-218000 Derived	-11390000	-14010000 Derived	Source 2005-07-01 – 2006-06-30: 22650000 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: -11608000 USD Inspect Operating Income Open source 2005-07-01 – 2006-06-30: -11390000 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: -13312000 USD Inspect Operating Cash Flow Open source 2005-07-01 – 2006-06-30: 698000 USD Inspect Capital Expenditure Open source
2007 2006-07-01 – 2007-06-30	47414000	61701000 Derived	-14287000	-715000 Derived	-13572000	-16434000 Derived	Source 2006-07-01 – 2007-06-30: 47414000 USD Inspect Revenue Open source 2006-07-01 – 2007-06-30: -14287000 USD Inspect Operating Income Open source 2006-07-01 – 2007-06-30: -13572000 USD Inspect Net Income Open source 2006-07-01 – 2007-06-30: -12390000 USD Inspect Operating Cash Flow Open source 2006-07-01 – 2007-06-30: 4044000 USD Inspect Capital Expenditure Open source
2008 2007-07-01 – 2008-06-30	67483000	98730000 Derived	-31247000	-1722000 Derived	-29525000	-29191000 Derived	Source 2007-07-01 – 2008-06-30: 67483000 USD Inspect Revenue Open source 2007-07-01 – 2008-06-30: -31247000 USD Inspect Operating Income Open source 2007-07-01 – 2008-06-30: -29525000 USD Inspect Net Income Open source 2007-07-01 – 2008-06-30: -24806000 USD Inspect Operating Cash Flow Open source 2007-07-01 – 2008-06-30: 4385000 USD Inspect Capital Expenditure Open source
2009 2008-07-01 – 2009-06-30	66518000	87387000 Derived	-20869000	250000 Derived	-21119000	-17664000 Derived	Source 2008-07-01 – 2009-06-30: 66518000 USD Inspect Revenue Open source 2008-07-01 – 2009-06-30: -20869000 USD Inspect Operating Income Open source 2008-07-01 – 2009-06-30: -21119000 USD Inspect Net Income Open source 2008-07-01 – 2009-06-30: -16657000 USD Inspect Operating Cash Flow Open source 2008-07-01 – 2009-06-30: 1007000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 66.5M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-06-30	Revenue	22650000	Revenue: 22650000 Open source
20072007-06-30	Revenue	47414000	Revenue: 47414000 Open source
20082008-06-30	Revenue	67483000	Revenue: 67483000 Open source
20092009-06-30	Revenue	66518000	Revenue: 66518000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-1.4% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-06-30	Year over year	No prior comparable period	Revenue: 22650000 Open source
20072007-06-30	Year over year	109.3%	Revenue: 47414000 Open source Revenue: 22650000 Open source
20082008-06-30	Year over year	42.3%	Revenue: 67483000 Open source Revenue: 47414000 Open source
20092009-06-30	Year over year	-1.4%	Revenue: 66518000 Open source Revenue: 67483000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -31.4% 2009

Net margin -31.7% 2009

Free cash flow margin -26.6% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20062006-06-30	Operating margin	-51.2%	Operating Income: -11608000 Open source Revenue: 22650000 Open source
20072007-06-30	Operating margin	-30.1%	Operating Income: -14287000 Open source Revenue: 47414000 Open source
20082008-06-30	Operating margin	-46.3%	Operating Income: -31247000 Open source Revenue: 67483000 Open source
20092009-06-30	Operating margin	-31.4%	Operating Income: -20869000 Open source Revenue: 66518000 Open source
20062006-06-30	Net margin	-50.3%	Net Income: -11390000 Open source Revenue: 22650000 Open source
20072007-06-30	Net margin	-28.6%	Net Income: -13572000 Open source Revenue: 47414000 Open source
20082008-06-30	Net margin	-43.8%	Net Income: -29525000 Open source Revenue: 67483000 Open source
20092009-06-30	Net margin	-31.7%	Net Income: -21119000 Open source Revenue: 66518000 Open source
20062006-06-30	Free cash flow margin	-61.9%	Revenue: 22650000 Open source Operating Cash Flow: -13312000 Open source Capital Expenditure: 698000 Open source
20072007-06-30	Free cash flow margin	-34.7%	Revenue: 47414000 Open source Operating Cash Flow: -12390000 Open source Capital Expenditure: 4044000 Open source
20082008-06-30	Free cash flow margin	-43.3%	Revenue: 67483000 Open source Operating Cash Flow: -24806000 Open source Capital Expenditure: 4385000 Open source
20092009-06-30	Free cash flow margin	-26.6%	Revenue: 66518000 Open source Operating Cash Flow: -16657000 Open source Capital Expenditure: 1007000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -16.7M 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-06-30	Operating cash flow	-13312000	Operating Cash Flow: -13312000 Open source
20072007-06-30	Operating cash flow	-12390000	Operating Cash Flow: -12390000 Open source
20082008-06-30	Operating cash flow	-24806000	Operating Cash Flow: -24806000 Open source
20092009-06-30	Operating cash flow	-16657000	Operating Cash Flow: -16657000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -17.7M 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-06-30	Free cash flow	-14010000	Operating Cash Flow: -13312000 Open source Capital Expenditure: 698000 Open source
20072007-06-30	Free cash flow	-16434000	Operating Cash Flow: -12390000 Open source Capital Expenditure: 4044000 Open source
20082008-06-30	Free cash flow	-29191000	Operating Cash Flow: -24806000 Open source Capital Expenditure: 4385000 Open source
20092009-06-30	Free cash flow	-17664000	Operating Cash Flow: -16657000 Open source Capital Expenditure: 1007000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

11.2% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2006-06-30	Liabilities / assets	Not reported	No source recorded
20072007-06-30	Liabilities / assets	31.5%	Total Liabilities: 11811000 Open source Total Assets: 37499000 Open source
20082008-06-30	Liabilities / assets	13.1%	Total Liabilities: 12427000 Open source Total Assets: 94570000 Open source
20092009-06-30	Liabilities / assets	11.2%	Total Liabilities: 8046000 Open source Total Assets: 71667000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.73× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2006-06-30	Current assets / current liabilities	Not reported	No source recorded
20072007-06-30	Current assets / current liabilities	2.69×	Current Assets: 31655000 Open source Current Liabilities: 11775000 Open source
20082008-06-30	Current assets / current liabilities	6.61×	Current Assets: 81697000 Open source Current Liabilities: 12367000 Open source
20092009-06-30	Current assets / current liabilities	7.73×	Current Assets: 61955000 Open source Current Liabilities: 8018000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2005-07-01 – 2006-06-30	−USD 11.39 million Exact value Exact value: -11390000 USD 2005-07-01 – 2006-06-30: -11390000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOFORM MEDICAL INC · 2006-06-30 BIOFORM MEDICAL INC (edgar:1282393) Net Income: -11390000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: -11390000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-08-201634.txt#7169 The citation records this snapshot. The page link may show a newer release later.	−USD 13.31 million Exact value Exact value: -13312000 USD 2005-07-01 – 2006-06-30: -13312000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOFORM MEDICAL INC · 2006-06-30 BIOFORM MEDICAL INC (edgar:1282393) Operating Cash Flow: -13312000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13312000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-08-201634.txt#7435 The citation records this snapshot. The page link may show a newer release later.	USD 698,000 Exact value Exact value: 698000 USD 2005-07-01 – 2006-06-30: 698000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOFORM MEDICAL INC · 2006-06-30 BIOFORM MEDICAL INC (edgar:1282393) Capital Expenditure: 698000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 698000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-08-201634.txt#7477 The citation records this snapshot. The page link may show a newer release later.	−USD 14.01 million Calculation and evidence -13312000 − 698000 USD Exact free cash flow: -14010000 USD 2005-07-01 – 2006-06-30: -13312000 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 698000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOFORM MEDICAL INC · 2006-06-30 BIOFORM MEDICAL INC (edgar:1282393) Free cash flow: -14010000 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13312000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-08-201634.txt#7435 Input fundies:CapitalExpenditure: 698000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-08-201634.txt#7477 The citation records this snapshot. The page link may show a newer release later.
2007 2006-07-01 – 2007-06-30	−USD 13.57 million Exact value Exact value: -13572000 USD 2006-07-01 – 2007-06-30: -13572000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOFORM MEDICAL INC · 2007-06-30 BIOFORM MEDICAL INC (edgar:1282393) Net Income: -13572000 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: -13572000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7192 The citation records this snapshot. The page link may show a newer release later.	−USD 12.39 million Exact value Exact value: -12390000 USD 2006-07-01 – 2007-06-30: -12390000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOFORM MEDICAL INC · 2007-06-30 BIOFORM MEDICAL INC (edgar:1282393) Operating Cash Flow: -12390000 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12390000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444 The citation records this snapshot. The page link may show a newer release later.	USD 4.04 million Exact value Exact value: 4044000 USD 2006-07-01 – 2007-06-30: 4044000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOFORM MEDICAL INC · 2007-06-30 BIOFORM MEDICAL INC (edgar:1282393) Capital Expenditure: 4044000 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ACapitalExpenditure&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4044000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486 The citation records this snapshot. The page link may show a newer release later.	−USD 16.43 million Calculation and evidence -12390000 − 4044000 USD Exact free cash flow: -16434000 USD 2006-07-01 – 2007-06-30: -12390000 USD · Inspect Operating Cash Flow · Source 2006-07-01 – 2007-06-30: 4044000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOFORM MEDICAL INC · 2007-06-30 BIOFORM MEDICAL INC (edgar:1282393) Free cash flow: -16434000 USD Concept: free-cash-flow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12390000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444 Input fundies:CapitalExpenditure: 4044000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486 The citation records this snapshot. The page link may show a newer release later.
2008 2007-07-01 – 2008-06-30	−USD 29.53 million Exact value Exact value: -29525000 USD 2007-07-01 – 2008-06-30: -29525000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOFORM MEDICAL INC · 2008-06-30 BIOFORM MEDICAL INC (edgar:1282393) Net Income: -29525000 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ANetIncome&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:NetIncome: -29525000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7192 The citation records this snapshot. The page link may show a newer release later.	−USD 24.81 million Exact value Exact value: -24806000 USD 2007-07-01 – 2008-06-30: -24806000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOFORM MEDICAL INC · 2008-06-30 BIOFORM MEDICAL INC (edgar:1282393) Operating Cash Flow: -24806000 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3AOperatingCashFlow&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24806000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444 The citation records this snapshot. The page link may show a newer release later.	USD 4.39 million Exact value Exact value: 4385000 USD 2007-07-01 – 2008-06-30: 4385000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOFORM MEDICAL INC · 2008-06-30 BIOFORM MEDICAL INC (edgar:1282393) Capital Expenditure: 4385000 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ACapitalExpenditure&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4385000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486 The citation records this snapshot. The page link may show a newer release later.	−USD 29.19 million Calculation and evidence -24806000 − 4385000 USD Exact free cash flow: -29191000 USD 2007-07-01 – 2008-06-30: -24806000 USD · Inspect Operating Cash Flow · Source 2007-07-01 – 2008-06-30: 4385000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOFORM MEDICAL INC · 2008-06-30 BIOFORM MEDICAL INC (edgar:1282393) Free cash flow: -29191000 USD Concept: free-cash-flow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24806000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444 Input fundies:CapitalExpenditure: 4385000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486 The citation records this snapshot. The page link may show a newer release later.
2009 2008-07-01 – 2009-06-30	−USD 21.12 million Exact value Exact value: -21119000 USD 2008-07-01 – 2009-06-30: -21119000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Net Income: -21119000 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: -21119000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7192 The citation records this snapshot. The page link may show a newer release later.	−USD 16.66 million Exact value Exact value: -16657000 USD 2008-07-01 – 2009-06-30: -16657000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Operating Cash Flow: -16657000 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16657000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444 The citation records this snapshot. The page link may show a newer release later.	USD 1.01 million Exact value Exact value: 1007000 USD 2008-07-01 – 2009-06-30: 1007000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Capital Expenditure: 1007000 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393/explain?concept=fundies%3ACapitalExpenditure&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1007000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486 The citation records this snapshot. The page link may show a newer release later.	−USD 17.66 million Calculation and evidence -16657000 − 1007000 USD Exact free cash flow: -17664000 USD 2008-07-01 – 2009-06-30: -16657000 USD · Inspect Operating Cash Flow · Source 2008-07-01 – 2009-06-30: 1007000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOFORM MEDICAL INC · 2009-06-30 BIOFORM MEDICAL INC (edgar:1282393) Free cash flow: -17664000 USD Concept: free-cash-flow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-04T13:24:15Z Snapshot: 6063c07a1b1be25180938803bc95f0a222bb3148e8bcd00f57045331cb8e8b14 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1282393?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16657000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7444 Input fundies:CapitalExpenditure: 1007000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1282393/0001193125-09-198308.txt#7486 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

10 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001282393, 1282393, edgar:1282393

BIOFORM MEDICAL INC

Latest quarter

Revenue

Net margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2008-07-01 – 2009-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation